These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

417 related articles for article (PubMed ID: 26834706)

  • 41. [The bacterial vaginosis--treatment problems].
    Romanik MK; Ekiel AM; Tomana L; Martirosian G
    Wiad Lek; 2007; 60(1-2):64-7. PubMed ID: 17607971
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Disruption of urogenital biofilms by lactobacilli.
    McMillan A; Dell M; Zellar MP; Cribby S; Martz S; Hong E; Fu J; Abbas A; Dang T; Miller W; Reid G
    Colloids Surf B Biointerfaces; 2011 Aug; 86(1):58-64. PubMed ID: 21497071
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Gardnerella and vaginal health: the truth is out there.
    Rosca AS; Castro J; Sousa LGV; Cerca N
    FEMS Microbiol Rev; 2020 Jan; 44(1):73-105. PubMed ID: 31697363
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Crystal Violet Staining Alone Is Not Adequate to Assess Synergism or Antagonism in Multi-Species Biofilms of Bacteria Associated With Bacterial Vaginosis.
    Castro J; Lima Â; Sousa LGV; Rosca AS; Muzny CA; Cerca N
    Front Cell Infect Microbiol; 2021; 11():795797. PubMed ID: 35071046
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The lower genital tract microbiota in relation to cytokine-, SLPI- and endotoxin levels: application of checkerboard DNA-DNA hybridization (CDH).
    Nikolaitchouk N; Andersch B; Falsen E; Strömbeck L; Mattsby-Baltzer I
    APMIS; 2008 Apr; 116(4):263-77. PubMed ID: 18397461
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Dequalinium Chloride Effectively Disrupts Bacterial Vaginosis (BV)
    Gaspar C; Rolo J; Cerca N; Palmeira-de-Oliveira R; Martinez-de-Oliveira J; Palmeira-de-Oliveira A
    Pathogens; 2021 Feb; 10(3):. PubMed ID: 33668706
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Bacterial vaginosis: An insight into the prevalence, alternative treatments regimen and it's associated resistance patterns.
    Javed A; Parvaiz F; Manzoor S
    Microb Pathog; 2019 Feb; 127():21-30. PubMed ID: 30502515
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Evolving issues in understanding and treating bacterial vaginosis.
    Marrazzo JM
    Expert Rev Anti Infect Ther; 2004 Dec; 2(6):913-22. PubMed ID: 15566334
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The presence of the putative Gardnerella vaginalis sialidase A gene in vaginal specimens is associated with bacterial vaginosis biofilm.
    Hardy L; Jespers V; Van den Bulck M; Buyze J; Mwambarangwe L; Musengamana V; Vaneechoutte M; Crucitti T
    PLoS One; 2017; 12(2):e0172522. PubMed ID: 28241058
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Lysozyme as a cotreatment during antibiotics use against vaginal infections: An in vitro study on Gardnerella vaginalis biofilm models.
    Thellin O; Zorzi W; Zorzi D; Delvenne P; Heinen E; ElMoualij B; Quatresooz P
    Int Microbiol; 2016 Jun; 19(2):101-107. PubMed ID: 27845497
    [TBL] [Abstract][Full Text] [Related]  

  • 51. In-vitro and in-vivo activity of metronidazole against Gardnerella vaginalis, Bacteroides spp. and Mobiluncus spp. in bacterial vaginosis.
    Jones BM; Geary I; Alawattegama AB; Kinghorn GR; Duerden BI
    J Antimicrob Chemother; 1985 Aug; 16(2):189-97. PubMed ID: 3905748
    [TBL] [Abstract][Full Text] [Related]  

  • 52. A Cationic Amphipathic Tilapia Piscidin 4 Peptide-Based Antimicrobial Formulation Promotes Eradication of Bacterial Vaginosis-Associated Bacterial Biofilms.
    Lin WC; Chen YR; Chuang CM; Chen JY
    Front Microbiol; 2022; 13():806654. PubMed ID: 35444633
    [TBL] [Abstract][Full Text] [Related]  

  • 53. BV and non-BV associated Gardnerella vaginalis establish similar synergistic interactions with other BV-associated microorganisms in dual-species biofilms.
    Castro J; Cerca N
    Anaerobe; 2015 Dec; 36():56-9. PubMed ID: 26505928
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Throwing the dice for the diagnosis of vaginal complaints?
    Schwiertz A; Taras D; Rusch K; Rusch V
    Ann Clin Microbiol Antimicrob; 2006 Feb; 5():4. PubMed ID: 16503990
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Response of Gardnerella vaginalis biofilm to 5 days of moxifloxacin treatment.
    Swidsinski A; Dörffel Y; Loening-Baucke V; Schilling J; Mendling W
    FEMS Immunol Med Microbiol; 2011 Feb; 61(1):41-6. PubMed ID: 20955467
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Rapid and Profound Shifts in the Vaginal Microbiota Following Antibiotic Treatment for Bacterial Vaginosis.
    Mayer BT; Srinivasan S; Fiedler TL; Marrazzo JM; Fredricks DN; Schiffer JT
    J Infect Dis; 2015 Sep; 212(5):793-802. PubMed ID: 25676470
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Sensitive Detection of Thirteen Bacterial Vaginosis-Associated Agents Using Multiplex Polymerase Chain Reaction.
    Malaguti N; Bahls LD; Uchimura NS; Gimenes F; Consolaro ME
    Biomed Res Int; 2015; 2015():645853. PubMed ID: 26078959
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Nucleic acid-based diagnosis of bacterial vaginosis and improved management using probiotic lactobacilli.
    Reid G; Burton J; Hammond JA; Bruce AW
    J Med Food; 2004; 7(2):223-8. PubMed ID: 15298771
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The genital econiche: focus on microbiota and bacterial vaginosis.
    Danielsson D; Teigen PK; Moi H
    Ann N Y Acad Sci; 2011 Aug; 1230():48-58. PubMed ID: 21824165
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Prevalence and distribution of Gardnerella vaginalis subgroups in women with and without bacterial vaginosis.
    Janulaitiene M; Paliulyte V; Grinceviciene S; Zakareviciene J; Vladisauskiene A; Marcinkute A; Pleckaityte M
    BMC Infect Dis; 2017 Jun; 17(1):394. PubMed ID: 28583109
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.